Funder: National Institutes of Health (NIH)
Due Dates: February 10, 2026 (Estimated)
Funding Amounts: Award size not specified; cooperative agreement (UG3/UH3) mechanism; duration and budget details to be announced in full NOFO.
Summary: Supports exploratory and efficacy clinical trials for neurological disorders, including drugs, devices, and behavioral or rehabilitation therapies.
Key Information: Forecasted opportunity—specifics may change; applications not yet being accepted.